Section
Pipeline
Late-stage drugs with significant commercial implications
PipelineFiercePharma ↗
BeOne Medicines has entered the BCL-2 arena, securing an FDA green light for Beqalzi that carves out a unique …
PipelineEndpoints News ↗
A gene therapy designed by Encoded Therapeutics reduced seizures by 76% in children with Dravet syndrome, a se…
PipelineFiercePharma ↗
Eli Lilly and Novo Nordisk are building cases for their incretin drugs, both new and old, as attractive weight…
PipelineSTAT News ↗
The case for Makary as the WOAT, Cassidy's seat at risk ahead of midterms, and other biotech news from The Rea…
PipelineBriefing
Three months post-Avadel acquisition, Alkermes’ Lumryz met all endpoints in the phase 3 Revitalyz study for id…
PipelineSTAT News ↗
Doctors have linked a boy's tumor to a gene therapy, but say the rare risks need to be weighed against the pro…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.